Celebrate Clinical Trials Day with Us!
View Flyer Clinical Trials Day Eager Street Park | 1900 E. Eager Street Saturday, May 11, 204 | 11:00 am – 3:00 pm Join
ICTR in the News: Study Finds Injectable Drug Used to Treat Asthma and Other Allergic Conditions May Limit Reactions in People with Multiple Food Allergies
This article discusses the work of Robert Wood, MD, deputy director of Pediatric Research and associate program director of the ICTR Clinical Research Units (CRUs) Results
Enroll in OnCore Clinical Trial Management System Training by March 22
The Office of Clinical Trials and Health IT have partnered to bring OnCore, a leading clinical trial management system (CTMS), to Johns Hopkins Medicine. With this
Johns Hopkins Medicine Institutional Review Board (IRB) Now Offering Consultations
The Johns Hopkins Medicine Institutional Review Board (JHM IRB) now offers consultations. Need information to plan a new research study? Have questions about correspondence from
The Results Are In! Research Participants Rate Their Experiences
Johns Hopkins Medicine is committed to making the experience of being a research participant as positive as possible. Every six months, the ICTR randomly selects
Cell Engineering Team Links Cancer Drug to Potential Therapy for Alzheimer’s Disease and Long-COVID Risk for It
What Works for Cancer Immunotherapy May Also Work for Alzheimer’s Disease In experiments with lab-grown brain cells and mouse models, scientists at Johns Hopkins Medicine
Join Our Team!
Academic Program Administrator Job Req ID: 112811 We are seeking an Academic Program Administrator who will provide program support for Trainees, Scholars, and Program Faculty. Administration and
Training Opportunity for Clinical Researchers and Health System Leaders
Designed for faculty and staff engaged in clinical care delivery or its management Johns Hopkins recognizes that a learning health system mindset is central to
Age-Related Changes in Fibroblast Cells Promote Pancreatic Cancer Growth and Spread
Older people may be at greater risk of developing pancreatic cancer and have poorer prognoses because of age-related changes in cells in the pancreas called
Novel Drug Combination Shows Promise for Advanced HER2-Negative Breast Cancer
A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel
The Research Navigator’s Corner- January 2024
The Research Navigators regularly receive questions covering a wide range of topics about conducting research studies at Johns Hopkins. It is not uncommon for multiple
Johns Hopkins Researchers Make Progress Toward Developing Blood Tests for Psychiatric and Neurological Disorders
Researchers used genetic markers in maternal blood that serve as “stand-ins” for brain molecules Researchers in a Johns Hopkins Children’s Center-led study that used genetic
ICTR in the News: Johns Hopkins Children’s Center Study Finds Cost-Driven Housing Moves Lead to Disruptions in Federal Assistance Programs
This article discusses the work of Jacky Jennings, PhD, MPH, BIRCWH Award program mentor. Across the United States, a growing number of families with low
Combination Drug Therapy Shows Promise for a Treatment-Resistant Cancer
A combination of two cancer drugs could be effective against malignant peripheral nerve sheath tumors (MPNSTs) — soft tissue tumors that are stubbornly resistant to